MICHAEL L PETERSON
CIK 1293970 · Chief Executive Officer · last filed 2025-07-08
MICHAEL L PETERSON is a Chief Executive Officer who has filed 45 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing shows the insider was granted $180.0K of WGRX on Jul 8, 2025. Across all open-market trades the lifetime net is −$719.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $305.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$305.6K
5
45
-$719.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGRX | Director | 4,000 | $3.52 | $14.1K | $0 | 1 | 2025-07-08 |
| TPET | Chief Executive Officer | 59,250 | $0.27 | $15.8K | $0 | 2 | 2023-10-30 |
| Ocean Biomedical, Inc. (OCEAW) Delisted | Director | 80,000 | $0.03 | $2.4K | $0 | 1 | 2023-03-02 |
| MEDS | Director | 8,156 | $3.55 | $29.0K | -$17.7K | 6 | 2023-01-20 |
| PED | President and CEO | 22,130 | $11.15 | $246.7K | -$702.1K | 25 | 2018-06-29 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-08 | WGRX | Grant (A) | −200,000 | -$180.0K | EDGAR |
| 2023-10-30 | TPET | Grant (A) | +1,000,000 | $0 | EDGAR |
| 2023-09-06 | TPET | Grant (A) | +125,000 | $0 | EDGAR |
| 2023-03-02 | Ocean Biomedical, Inc. (OCEAW) Delisted | Other (J) | +80,000 | $0 | EDGAR |
| 2023-02-17 | — | Grant (A) | — | $0 | |
| 2023-01-20 | MEDS | Grant (A) | +100,000 | $0 | EDGAR |
| 2021-06-22 | MEDS | Sell (S) | −900 | -$4.0K | EDGAR |
| 2021-06-02 | MEDS | Disp (D) | −8,041 | $0 | EDGAR |
| 2021-04-20 | MEDS | Mixed | +9,821 | $50.8K | EDGAR |
| 2020-12-15 | MEDS | Sell (S) | −1,800 | -$9.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.